SouthState’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
SouthState's MRNA Position: Q3 2026 in Review
SouthState increased its Moderna (MRNA) stake by 64% in Q3 2026, buying an estimated $2.69K and bringing the position to 64 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #686.
SouthState first reported a position in MRNA in Q3 2021 and has held it in 17 quarters since. The position peaked at $58K in Q3 2021. 875 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- SouthState held 64 shares of Moderna worth $12.4K as of Q3 2026.
- SouthState bought 25 Moderna shares in Q3 2026, an estimated $2.69K.
- Moderna made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #686 holding.
- SouthState first reported a position in Moderna in Q3 2021 and has held it in 17 quarters since.
- SouthState's Moderna position peaked at $58K in Q3 2021.
- 875 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.